AIMEE DUTHIL: Open Payments
NPI 1891350559 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,490 in 51 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $870 · 2025 $1,490
Food & beverage: $1,467Education: $24
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 6 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $224 |
| AstraZeneca Pharmaceuticals LP | 3 | $205 |
| OPKO Pharmaceuticals, LLC | 13 | $162 |
| Amgen Inc. | 6 | $133 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Vantive US Healthcare LLC | 1 | $87 |
| Lilly USA, LLC | 4 | $79 |
| Ardelyx, Inc. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
Products named: Kerendia, RAYALDEE, Auryxia, JARDIANCE, LOKELMA, KRYSTEXXA, Vafseo, FARXIGA.
Industry payments across AL — which companies pay providers there.
